US5360897A
(en)
|
1981-08-31 |
1994-11-01 |
The University Of Rochester |
Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad
|
US4454121A
(en)
|
1982-07-27 |
1984-06-12 |
The University Of Tennessee Research Corporation |
Synthetic peptides corresponding to antigenic determinants of the M protein of Streptococcus pyogenes
|
SE8205892D0
(sv)
|
1982-10-18 |
1982-10-18 |
Bror Morein |
Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
IL73534A
(en)
|
1983-11-18 |
1990-12-23 |
Riker Laboratories Inc |
1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
|
US5916588A
(en)
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
US6090406A
(en)
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
ES2061500T5
(es)
|
1986-06-17 |
2003-05-16 |
Chiron Corp |
Diagnosis y vacunas de la hepatitis delta, su preparacion y uso.
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
US5098827A
(en)
|
1988-02-26 |
1992-03-24 |
The University Of Florida |
Novel bacterial markers for pathogenic group B streptococci
|
AU631377B2
(en)
|
1988-08-25 |
1992-11-26 |
Liposome Company, Inc., The |
Affinity associated vaccine
|
GB8827038D0
(en)
|
1988-11-18 |
1988-12-21 |
Kehoe M |
Streptolysin o antigens & uses
|
US5354846A
(en)
|
1988-11-18 |
1994-10-11 |
Michael Kehoe |
Streptolysin O antigen derivatives, its production and uses
|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
US5238944A
(en)
|
1988-12-15 |
1993-08-24 |
Riker Laboratories, Inc. |
Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
|
EP0449856B1
(en)
|
1988-12-16 |
2001-09-12 |
De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur |
Pneumolysin mutants and pneumococcal vaccines made therefrom
|
GB2233977B
(en)
|
1989-01-04 |
1993-03-31 |
Michael Kehoe |
Cytolytic streptolysin o mutants and uses
|
ES2055785T3
(es)
|
1989-01-17 |
1994-09-01 |
Eniricerche Spa |
Peptidos sinteticos y su uso como vehiculos universales para la preparacion de conjugados inmunogenos aptos para el desarrollo de vacunas sinteticas.
|
US4929624A
(en)
|
1989-03-23 |
1990-05-29 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
|
JPH0832638B2
(ja)
|
1989-05-25 |
1996-03-29 |
カイロン コーポレイション |
サブミクロン油滴乳剤を含んで成るアジュバント製剤
|
WO1991001146A1
(en)
|
1989-07-14 |
1991-02-07 |
Praxis Biologics, Inc. |
Cytokine and hormone carriers for conjugate vaccines
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
US5821088A
(en)
|
1990-05-11 |
1998-10-13 |
Siga Pharmaceuticals, Inc. |
Use of gram-positive bacteria to express recombinant proteins
|
US6737521B1
(en)
|
1990-05-11 |
2004-05-18 |
The Rockefeller University |
Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
|
GB2276169A
(en)
|
1990-07-05 |
1994-09-21 |
Celltech Ltd |
Antibodies specific for carcinoembryonic antigen
|
EP0471177B1
(en)
|
1990-08-13 |
1995-10-04 |
American Cyanamid Company |
Filamentous hemagglutinin of bordetella pertussis as a carrier molecule for conjugate vaccines
|
US5153312A
(en)
|
1990-09-28 |
1992-10-06 |
American Cyanamid Company |
Oligosaccharide conjugate vaccines
|
US5389640A
(en)
|
1991-03-01 |
1995-02-14 |
Minnesota Mining And Manufacturing Company |
1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
DE69228247T2
(de)
|
1991-08-10 |
1999-07-08 |
Medical Research Council, London |
Behandlung von Zellpopulationen
|
US5391712A
(en)
|
1991-08-30 |
1995-02-21 |
Beckman Instruments, Inc. |
Non-hemolytic streptolysin O variants
|
US5378620A
(en)
|
1991-08-30 |
1995-01-03 |
Beckman Instruments, Inc. |
Streptolysin O derivatives
|
US5268376A
(en)
|
1991-09-04 |
1993-12-07 |
Minnesota Mining And Manufacturing Company |
1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
US5266575A
(en)
|
1991-11-06 |
1993-11-30 |
Minnesota Mining And Manufacturing Company |
2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
|
JP3368902B2
(ja)
|
1992-03-02 |
2003-01-20 |
カイロン エセ.ピー.アー. |
ワクチンおよび診断に有用なHelicobacterpyloriタンパク質
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
ES2108278T3
(es)
|
1992-06-25 |
1997-12-16 |
Smithkline Beecham Biolog |
Composicion de vacuna con coadyuvantes.
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
DE4240056A1
(de)
|
1992-11-28 |
1994-06-01 |
Boehringer Mannheim Gmbh |
Streptolysin O Peptidantigene und Verfahren zur Bestimmung von Streptolysin-Antikörper
|
EP0672142B1
(en)
|
1992-12-04 |
2001-02-28 |
Medical Research Council |
Multivalent and multispecific binding proteins, their manufacture and use
|
US5395937A
(en)
|
1993-01-29 |
1995-03-07 |
Minnesota Mining And Manufacturing Company |
Process for preparing quinoline amines
|
ATE260976T1
(de)
|
1993-02-01 |
2004-03-15 |
Beckman Coulter Inc |
Mitogener faktor, sein gen und verfahren zur dessen mikrodetektion
|
WO1994021292A1
(en)
|
1993-03-23 |
1994-09-29 |
Smithkline Beecham Biologicals (S.A.) |
Vaccine compositions containing 3-o deacylated monophosphoryl lipid a
|
EP1380648A3
(en)
|
1993-06-23 |
2004-04-14 |
Beckman Coulter, Inc. |
Recombinant DNAase B derived from streptococcus pyogenes
|
US5352784A
(en)
|
1993-07-15 |
1994-10-04 |
Minnesota Mining And Manufacturing Company |
Fused cycloalkylimidazopyridines
|
CZ288182B6
(en)
|
1993-07-15 |
2001-05-16 |
Minnesota Mining & Mfg |
Imidazo[4,5-c]pyridine-4-amines and pharmaceutical preparations based thereon
|
US5585098A
(en)
|
1993-11-23 |
1996-12-17 |
Ovimmune, Inc. |
Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants
|
GB9326174D0
(en)
|
1993-12-22 |
1994-02-23 |
Biocine Sclavo |
Mucosal adjuvant
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
PT804559E
(pt)
|
1994-10-07 |
2005-08-31 |
Univ Rockefeller |
Enzima para clivagem da regiao ancora de proteinas de superficie de bacterias gram-positivas
|
AUPM873294A0
(en)
|
1994-10-12 |
1994-11-03 |
Csl Limited |
Saponin preparations and use thereof in iscoms
|
AUPM885194A0
(en)
|
1994-10-14 |
1994-11-10 |
Council Of The Queensland Institute Of Medical Research, The |
Synthetic peptides and vaccines comprising same
|
US5482936A
(en)
|
1995-01-12 |
1996-01-09 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-C]quinoline amines
|
IL117483A
(en)
|
1995-03-17 |
2008-03-20 |
Bernard Brodeur |
MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
US6284884B1
(en)
|
1995-06-07 |
2001-09-04 |
North American Vaccine, Inc. |
Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
|
US6936259B2
(en)
|
1995-06-08 |
2005-08-30 |
University Of Saskatchewan |
CAMP factor of Streptococcus uberis
|
GB9513261D0
(en)
|
1995-06-29 |
1995-09-06 |
Smithkline Beecham Biolog |
Vaccines
|
US6355255B1
(en)
|
1998-12-07 |
2002-03-12 |
Regents Of The University Of Minnesota |
Streptococcal C5a peptidase vaccine
|
US5846547A
(en)
|
1996-01-22 |
1998-12-08 |
Regents Of The University Of Minnesota |
Streptococcal C5a peptidase vaccine
|
EP0907738A1
(en)
|
1996-04-02 |
1999-04-14 |
Smithkline Beecham Corporation |
Novel compounds
|
EP0934336A1
(en)
|
1996-05-14 |
1999-08-11 |
Smithkline Beecham Corporation |
Novel compounds
|
US6346392B1
(en)
|
1996-11-27 |
2002-02-12 |
Smithkline Beecham Corporation |
Polynucleotides encoding a novel glutamine transport ATP-binding protein
|
IES960488A2
(en)
|
1996-07-03 |
1997-11-19 |
Trinity College Dublin |
Subunit Vaccine for Streptococcus Equi
|
EP0821070A1
(en)
|
1996-07-22 |
1998-01-28 |
Carelli, Claude Marcel Henri |
Pit-1 gene polymorphism and trait selection in animals
|
DE19630390A1
(de)
|
1996-07-26 |
1998-01-29 |
Chiron Behring Gmbh & Co |
Proteine, insbesondere Membranproteine von Helicobacter pylori, ihre Herstellung und Verwendung
|
EP0970966B1
(en)
|
1996-09-04 |
2008-02-20 |
Takara Bio Inc. |
Fungal antigens and process for producing the same
|
EP0942983B2
(en)
|
1996-10-31 |
2014-09-10 |
Human Genome Sciences, Inc. |
Streptococcus pneumoniae antigens and vaccines
|
JP2001510989A
(ja)
|
1996-11-01 |
2001-08-07 |
スミスクライン・ビーチャム・コーポレイション |
新規コーディング配列
|
DE69830305T2
(de)
|
1997-02-20 |
2006-02-02 |
Dime, David S., Toronto |
Ortsspezifische arzneimittel verabreichung
|
US7033765B1
(en)
|
1997-02-20 |
2006-04-25 |
Toronto Research Chemicals, Inc. |
Site-specific drug delivery
|
EP1005368B1
(en)
|
1997-03-10 |
2009-09-02 |
Ottawa Hospital Research Institute |
Use of nucleic acids containing unmethylated CpG dinucleotide in combination with alum as adjuvants
|
US6426074B1
(en)
|
1997-03-19 |
2002-07-30 |
The Brigham And Women's Hospital Inc. |
Group B Streptococcus vaccine
|
US6818222B1
(en)
|
1997-03-21 |
2004-11-16 |
Chiron Corporation |
Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
|
US6299881B1
(en)
|
1997-03-24 |
2001-10-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
|
EP0981625A2
(en)
|
1997-05-06 |
2000-03-01 |
Human Genome Sciences, Inc. |
$i(ENTEROCOCCUS FAECALIS) POLYNUCLEOTIDES AND POLYPEPTIDES
|
US6635623B1
(en)
|
1997-06-13 |
2003-10-21 |
Baylor College Of Medicine |
Lipoproteins as nucleic acid vectors
|
GB9712347D0
(en)
|
1997-06-14 |
1997-08-13 |
Smithkline Beecham Biolog |
Vaccine
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
US6800744B1
(en)
|
1997-07-02 |
2004-10-05 |
Genome Therapeutics Corporation |
Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
|
WO1999006951A1
(en)
|
1997-07-31 |
1999-02-11 |
Intergraph Corporation |
Alignment and distribution apparatus and method
|
EP1009382B1
(en)
|
1997-09-05 |
2003-06-18 |
GlaxoSmithKline Biologicals S.A. |
Oil in water emulsions containing saponins
|
AU751009B2
(en)
|
1997-09-12 |
2002-08-08 |
University Of Tennessee Research Corporation, The |
Group A streptococcal vaccines
|
US6406883B1
(en)
|
1997-09-26 |
2002-06-18 |
Luetticken Rudolf |
Lmb gene of Streptococcus agalactiae
|
AU9507698A
(en)
|
1997-09-26 |
1999-04-23 |
Med Immune, Inc. |
(lmb) gene of (streptococcus agalactiae)
|
US6756361B1
(en)
|
1997-10-14 |
2004-06-29 |
Nabi |
Enterococcus antigens and vaccines
|
JP4402290B2
(ja)
|
1997-10-17 |
2010-01-20 |
ソシエテ・デ・プロデュイ・ネスレ・エス・アー |
新規な乳酸菌種
|
CA2308606A1
(en)
|
1997-11-06 |
1999-05-20 |
Chiron S.P.A. |
Neisserial antigens
|
DK1032674T3
(da)
|
1997-11-21 |
2007-04-10 |
Serono Genetics Inst Sa |
Chlamydia pneumoniae genomisk sekvens og polypeptider, fragmenter deraf og anvendelser deraf, især til diagnosen, forebyggelsen og behandlingen af infektion
|
WO1999026969A1
(en)
|
1997-11-21 |
1999-06-03 |
University Of Otago |
Zoocin a immunity factor
|
WO1999028475A2
(en)
|
1997-11-28 |
1999-06-10 |
Genset |
Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
|
GB9725084D0
(en)
|
1997-11-28 |
1998-01-28 |
Medeva Europ Ltd |
Vaccine compositions
|
WO1999027961A1
(en)
|
1997-12-02 |
1999-06-10 |
Powderject Vaccines, Inc. |
Transdermal delivery of particulate vaccine compositions
|
AU1866099A
(en)
|
1997-12-31 |
1999-07-26 |
Stressgen Biotechnologies Corporation |
Streptococcal heat shock proteins of the hsp60 family
|
EP2278011A3
(en)
|
1998-01-14 |
2012-03-07 |
Novartis Vaccines and Diagnostics S.r.l. |
Neisseria meningitidis antigens
|
US7041814B1
(en)
|
1998-02-18 |
2006-05-09 |
Genome Therapeutics Corporation |
Nucleic acid and amino acid sequences relating to Enterobacter cloacae for diagnostics and therapeutics
|
TR200002437T2
(tr)
|
1998-02-20 |
2000-11-21 |
Biochem Pharma Inc. |
B grubu streptococcus antijenleri.
|
GB9807721D0
(en)
|
1998-04-08 |
1998-06-10 |
Chiron Spa |
Antigen
|
BR9909915A
(pt)
|
1998-04-09 |
2000-12-26 |
Smithkline Beecham Biolog |
Composições adjuvantes
|
GB9808327D0
(en)
|
1998-04-20 |
1998-06-17 |
Chiron Spa |
Antidiotypic compounds
|
AU761780B2
(en)
|
1998-05-01 |
2003-06-12 |
Glaxosmithkline Biologicals Sa |
Neisseria meningitidis antigens and compositions
|
GB9810193D0
(en)
|
1998-05-12 |
1998-07-08 |
Smithkline Beecham Biolog |
Novel compounds
|
US6562798B1
(en)
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
US6660520B2
(en)
|
1998-06-05 |
2003-12-09 |
Smithkline Beecham Corporation |
Nrde
|
DE69935986D1
(de)
|
1998-07-27 |
2007-06-14 |
Sanofi Pasteur Ltd |
Streptococcus pneumoniae proteine und nukleinsäuren
|
US6936252B2
(en)
|
1998-07-27 |
2005-08-30 |
Microbial Technics Limited |
Streptococcus pneumoniae proteins and nucleic acid molecules
|
WO2000006736A2
(en)
|
1998-07-27 |
2000-02-10 |
Microbial Technics Limited |
Nucleic acids and proteins from group b streptococcus
|
US7098182B2
(en)
|
1998-07-27 |
2006-08-29 |
Microbial Technics Limited |
Nucleic acids and proteins from group B streptococcus
|
GB9819898D0
(en)
|
1998-09-11 |
1998-11-04 |
Smithkline Beecham Plc |
New vaccine and method of use
|
MXPA01003557A
(es)
|
1998-10-09 |
2004-04-05 |
Chiron Corp |
Secuencias genomicas de neisseria y metodos para su uso.
|
US6175001B1
(en)
|
1998-10-16 |
2001-01-16 |
The Scripps Research Institute |
Functionalized pyrimidine nucleosides and nucleotides and DNA's incorporating same
|
AU1722300A
(en)
|
1998-11-12 |
2000-05-29 |
Regents Of The University Of California, The |
Chlamydia pneumoniae genome sequence
|
GB9828000D0
(en)
|
1998-12-18 |
1999-02-10 |
Chiron Spa |
Antigens
|
US7128918B1
(en)
|
1998-12-23 |
2006-10-31 |
Id Biomedical Corporation |
Streptococcus antigens
|
DE60038166T2
(de)
|
1999-03-19 |
2009-03-12 |
Glaxosmithkline Biologicals S.A., Rixensart |
Impfstoff gegen bakterielle antigene
|
EP1165796A2
(en)
|
1999-04-09 |
2002-01-02 |
Techlab, Inc. |
Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
|
US6790950B2
(en)
|
1999-04-09 |
2004-09-14 |
Pharmacia & Upjohn Company |
Anti-bacterial vaccine compositions
|
US7101692B2
(en)
|
1999-04-15 |
2006-09-05 |
The Regents Of The University Of California |
Identification of sortase gene
|
AU784043B2
(en)
|
1999-04-15 |
2006-01-19 |
Regents Of The University Of California, The |
Identification of sortase gene
|
WO2000067161A2
(en)
|
1999-05-04 |
2000-11-09 |
Grant Lee H |
Method and apparatus for categorizing and retrieving network pages and sites
|
AU5755500A
(en)
|
1999-06-21 |
2001-01-09 |
University Of Utah Research Foundation |
Isolated genes from virulent group B streptococcus agalactiae
|
US6833356B1
(en)
|
1999-08-25 |
2004-12-21 |
Medimmune, Inc. |
Pneumococcal protein homologs and fragments for vaccines
|
GB9921125D0
(en)
|
1999-09-07 |
1999-11-10 |
Microbial Technics Limited |
Proteins
|
AU7721500A
(en)
|
1999-09-29 |
2001-04-30 |
Human Genome Sciences, Inc. |
Colon and colon cancer associated polynucleotides and polypeptides
|
EP2275129A3
(en)
|
2000-01-17 |
2013-11-06 |
Novartis Vaccines and Diagnostics S.r.l. |
Outer membrane vesicle (OMV) vaccine comprising N. meningitidis serogroup B outer membrane proteins
|
EP1311288A1
(en)
|
2000-01-20 |
2003-05-21 |
Ottawa Health Research Institute |
Immunostimulatory nucleic acids for inducing a th2 immune response
|
US6777547B1
(en)
|
2000-01-31 |
2004-08-17 |
Andreas Podbielski |
Collagen-binding proteins from streptococcus pyogenes
|
KR20020097200A
(ko)
|
2000-03-21 |
2002-12-31 |
엘리트라 파마슈티컬즈, 인코포레이티드 |
원핵세포에서의 필수유전자의 동정
|
GB0007432D0
(en)
|
2000-03-27 |
2000-05-17 |
Microbiological Res Authority |
Proteins for use as carriers in conjugate vaccines
|
AUPQ801700A0
(en)
|
2000-06-07 |
2000-06-29 |
Peplin Research Pty Ltd |
Enzyme and viral activation
|
AU2001272497A1
(en)
|
2000-06-23 |
2002-01-02 |
Bayer Aktiengesellschaft |
Regulation of human mast cell protease 6-like enzyme
|
US20040005667A1
(en)
|
2000-07-03 |
2004-01-08 |
Giuloi Ratti |
Immunisation against chlamydia pneumoniae
|
BR0112497A
(pt)
|
2000-07-06 |
2003-11-25 |
Shire Biochem Inc |
Antìgenos de streptococcus pyogenes
|
US7128919B2
(en)
|
2000-08-08 |
2006-10-31 |
St. Jude Children's Research Hospital |
Group B streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
|
AU8743001A
(en)
|
2000-08-28 |
2002-03-13 |
Aventis Pasteur |
Moraxella polypeptides and corresponding dna fragments and uses thereof
|
ATE384072T1
(de)
|
2000-09-26 |
2008-02-15 |
Idera Pharmaceuticals Inc |
Modulation der immunostimulatorischen aktivität von immunostimulierenden oligonukleotidanaloga durch positionelle chemische veränderungen
|
US7160547B2
(en)
|
2000-10-10 |
2007-01-09 |
University Of Tennessee Research Corporation |
Streptococcal streptolysin S vaccines
|
WO2002057315A2
(en)
|
2000-10-10 |
2002-07-25 |
University Of Tennessee Research Corporation |
Streptococcal streptolysin s vaccines
|
MX357775B
(es)
|
2000-10-27 |
2018-07-20 |
J Craig Venter Inst Inc |
Acidos nucleicos y proteinas de los grupos a y b de estreptococos.
|
GB0103424D0
(en)
|
2001-02-12 |
2001-03-28 |
Chiron Spa |
Gonococcus proteins
|
AU2002250071B2
(en)
|
2001-02-13 |
2008-02-14 |
Government Of The United States, As Represented By The Secretary Of The Army |
Vaccine for transcutaneous immunization
|
AU2002252378B2
(en)
|
2001-03-19 |
2007-10-18 |
Intercell Usa, Inc. |
Transcutaneous immunostimulation
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
US20070128229A1
(en)
|
2002-04-12 |
2007-06-07 |
Wyeth |
Surface proteins of Streptococcus pyogenes
|
KR100923598B1
(ko)
|
2001-04-13 |
2009-10-23 |
와이어쓰 |
스트렙토코커스 피오게네스의 표면 단백질
|
FR2824074A1
(fr)
|
2001-04-26 |
2002-10-31 |
Pasteur Institut |
Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
|
ATE557041T1
(de)
|
2001-05-18 |
2012-05-15 |
Us Gov Health & Human Serv |
Peptid-vakzinen gegen streptokokken der gruppe a
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
US20060073530A1
(en)
|
2001-08-15 |
2006-04-06 |
Olaf Schneewind |
Methods and compositions involving sortase B
|
EP1425040A2
(en)
|
2001-09-14 |
2004-06-09 |
Cytos Biotechnology AG |
In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
|
ATE447967T1
(de)
|
2001-09-14 |
2009-11-15 |
Cytos Biotechnology Ag |
Verpackung von immunstimulierendem cpg in virusähnlichen partikeln: herstellungsverfahren und verwendung
|
GB0123580D0
(en)
|
2001-10-01 |
2001-11-21 |
Glaxosmithkline Biolog Sa |
Vaccine
|
WO2003035836A2
(en)
|
2001-10-24 |
2003-05-01 |
Hybridon Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
|
US20040029129A1
(en)
|
2001-10-25 |
2004-02-12 |
Liangsu Wang |
Identification of essential genes in microorganisms
|
ATE406912T1
(de)
|
2001-12-12 |
2008-09-15 |
Novartis Vaccines & Diagnostic |
Immunisierung gegen chlamydia tracheomatis
|
WO2003068813A2
(en)
|
2002-02-11 |
2003-08-21 |
Shire Biochem Inc |
Group b streptococcus antigen
|
GB0203403D0
(en)
|
2002-02-13 |
2002-04-03 |
Chiron Spa |
Chlamydia cytotoxic-T cell epitopes
|
GB2385274B
(en)
|
2002-02-13 |
2004-04-14 |
Ming-Jeng Shue |
Vaginal suppository delivery device
|
US20050181388A1
(en)
|
2002-04-02 |
2005-08-18 |
Affinium Pharmaceuticals, Inc. |
Novel purified polypeptides from bacteria
|
AU2003213949A1
(en)
|
2002-04-08 |
2003-10-27 |
Affinium Pharmaceuticals, Inc. |
Purified polypeptides involved in membrane biogenesis
|
GB0210128D0
(en)
|
2002-05-02 |
2002-06-12 |
Chiron Spa |
Nucleic acids and proteins from streptococcus groups A & B
|
AU2003260102A1
(en)
|
2002-08-26 |
2004-03-11 |
Chiron Corporation |
Conserved and specific streptococcal genomes
|
EP1551357B1
(en)
|
2002-09-13 |
2014-07-16 |
Novartis Vaccines and Diagnostics, Inc. |
Group b streptococcus vaccine
|
TW566366U
(en)
|
2002-09-27 |
2003-12-11 |
Wus Tech Co Ltd |
Labor-saving portable battery equipment for power-driven walking assisted scooter
|
WO2004035618A2
(en)
|
2002-10-15 |
2004-04-29 |
Intercell Ag |
Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof
|
CA2511646A1
(en)
|
2002-12-27 |
2004-07-22 |
Chiron Corporation |
Thiosemicarbazones as anti-virals and immunopotentiators
|
CA2513655C
(en)
|
2003-01-21 |
2011-11-22 |
Chiron Corporation |
Use of tryptanthrin compounds for immune potentiation
|
EP2287311A1
(en)
*
|
2003-03-04 |
2011-02-23 |
Intercell AG |
Streptococcus pyogenes antigens
|
US20060257852A1
(en)
|
2003-04-10 |
2006-11-16 |
Chiron Corporation |
Severe acute respiratory syndrome coronavirus
|
EP2289907A3
(en)
|
2003-05-07 |
2011-08-31 |
Intercell AG |
Streptococcus agalactiae antigens I + II
|
RU2352356C2
(ru)
|
2003-06-26 |
2009-04-20 |
Новартис Вэксинес Энд Дайэгностикс, Инк. |
ИММУНОГЕННАЯ КОМПОЗИЦИЯ НА ОСНОВЕ АНТИГЕНА Chlamydia trachomatis (ВАРИАНТЫ) И ЕЕ ИСПОЛЬЗОВАНИЕ
|
EP1648500B1
(en)
*
|
2003-07-31 |
2014-07-09 |
Novartis Vaccines and Diagnostics, Inc. |
Immunogenic compositions for streptococcus pyogenes
|
AU2003904237A0
(en)
|
2003-08-08 |
2003-08-21 |
Garvan Institute Of Medical Research |
Novel translocation assay
|
US8945589B2
(en)
|
2003-09-15 |
2015-02-03 |
Novartis Vaccines And Diagnostics, Srl |
Immunogenic compositions for Streptococcus agalactiae
|
CA2537742C
(en)
|
2003-09-15 |
2014-07-22 |
Chiron Corporation |
Immunogenic compositions for streptococcus agalactiae
|
WO2005076010A2
(en)
|
2004-02-06 |
2005-08-18 |
Council Of Scientific And Industrial Research |
Computational method for identifying adhesin and adhesin-like proteins of therapeutic potential
|
US20060041961A1
(en)
|
2004-03-25 |
2006-02-23 |
Abad Mark S |
Genes and uses for pant improvement
|
WO2005108419A1
(en)
|
2004-05-07 |
2005-11-17 |
Lea-Ann Kirkham |
Mutant cholesterol-binding cytolysin proteins
|
US20060165716A1
(en)
|
2004-07-29 |
2006-07-27 |
Telford John L |
Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
|
GB0421465D0
(en)
|
2004-09-27 |
2004-10-27 |
Chiron Srl |
Group A streptococcus protein
|
EP1817432A2
(en)
|
2004-10-05 |
2007-08-15 |
Wyeth a Corporation of the State of Delaware |
Probe arrays for detecting multiple strains of different species
|
EP1807446A2
(en)
*
|
2004-10-08 |
2007-07-18 |
Novartis Vaccines and Diagnostics, Inc. |
Immunogenic and therapeutic compositions for streptococcus pyogenes
|
CA2591510A1
(en)
|
2004-12-22 |
2006-06-29 |
Novartis Vaccines And Diagnostics, Inc. |
Group b streptococcus
|
GB0502096D0
(en)
|
2005-02-01 |
2005-03-09 |
Chiron Srl |
Purification of streptococcal capsular polysaccharide
|
GB0502095D0
(en)
|
2005-02-01 |
2005-03-09 |
Chiron Srl |
Conjugation of streptococcal capsular saccharides
|
EP1919934A2
(en)
|
2005-05-13 |
2008-05-14 |
Novartis Vaccines and Diagnostics, Inc. |
Serum resistance factors of gram positive bacteria
|
EP1770171A1
(en)
|
2005-09-29 |
2007-04-04 |
Universität Zu Köln |
DNA microarray for rapid identification of Candida albicans in blood cultures.
|
GB0522303D0
(en)
|
2005-11-01 |
2005-12-07 |
Chiron Srl |
Culture method
|
DK2054431T3
(da)
|
2006-06-09 |
2012-01-02 |
Novartis Ag |
Konformere af bakterielle adhæsiner
|
WO2008003515A1
(en)
*
|
2006-07-07 |
2008-01-10 |
Intercell Ag |
Small streptococcus pyogenes antigens and their use
|
US20110038879A1
(en)
|
2006-10-30 |
2011-02-17 |
Novartis Ag |
Immunogenic and therapeutic compositions for streptococcus pyogenes
|
AU2008299376B2
(en)
*
|
2007-09-12 |
2013-02-28 |
Glaxosmithkline Biologicals S.A. |
GAS57 mutant antigens and GAS57 antibodies
|